Curative Biotechnology, Inc.

OTC: CUBT · Healthcare · Biotechnology

PublicHQ Palm Beach Gardens, FL · Palm BeachCIK 0001400271Reports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 48

v0.1 · 5/100 weight · pillars only

↑ listing tenure, market scale · ↓ Piotroski F, workforce scale

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

—

Employees

as of 2026-08-23

Market cap

$6.8M

as of 2026-08-23

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Curative Biotechnology, Inc.’s financial profile?

Curative Biotechnology, Inc. has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

Univec, Inc.——Apimeds Pharmaceuticals US, Inc——Liminatus Pharma, Inc. Class A Common Stock——Curanex Pharmaceuticals Inc Common Stock——Imagion Biosystems Limited——Acurx Pharmaceuticals, Inc.——

Neighbors

Palm Beach →

NextEra Energy, Inc.$25.8B77B+Monolithic Power Systems, Inc.$2.8B82B+Carrier Global Corporation$21.7B63C SBA Communications Corporation$244.5M66B Dycom Industries, Inc.$5.5B70B Celsius Holdings, Inc.$2.5B63C

Key facts

CEOI. Richard Garr

SectorHealthcare

IndustryBiotechnology

HeadquartersPalm Beach Gardens, FL

ExchangeOTC: CUBT

Employees4

IPO date1998-03-30

Latest filings

No filings loaded.

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.